BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005

HIV Med. 2005 Jul:6 Suppl 2:62-83. doi: 10.1111/j.1468-1293.2005.00293.x.

Authors

A L Pozniak¹, R F Miller, M C I Lipman, A R Freedman, L P Ormerod, M A Johnson, S Collins, S B Lucas; BHIVA Guidelines Writing Committee

Affiliation

¹ Chelsea and Westminster NHS Healthcare Trust, London, UK. anton.pozniak@chelwest.nhs.uk

PMID: 16011537
DOI: 10.1111/j.1468-1293.2005.00293.x

No abstract available

Publication types

Practice Guideline

MeSH terms

Antiretroviral Therapy, Highly Active* / adverse effects
Antitubercular Agents / adverse effects
Antitubercular Agents / therapeutic use*
Breast Feeding
Directly Observed Therapy
Drug Interactions
Drug Resistance, Viral
Female
HIV Infections / complications
HIV Infections / drug therapy*
Humans
Pregnancy
Pregnancy Complications / prevention & control
Secondary Prevention
Treatment Failure
Tuberculin Test
Tuberculosis / complications
Tuberculosis / drug therapy*
Tuberculosis / prevention & control
Tuberculosis, Multidrug-Resistant / complications
Tuberculosis, Multidrug-Resistant / drug therapy

Substances

Antitubercular Agents